Press release
Exocrine Pancreatic Insufficiency Market to reach USD 3.75 billion by 2029, registering a CAGR of 6.50%,Trends
Exocrine pancreatic insufficiency (EPI) is a condition caused by a lack of exocrine pancreatic enzymes, which causes maldigestion or inability to digest food. EPI has been linked to a variety of pancreatic disorders and syndromes, including cystic fibrosis, chronic pancreatitis, Shwachman-Diamond syndrome, and others. Pancreatic enzyme replacement therapy (PERT) is the first-line treatment in individuals with exocrine pancreatic insufficiency. Treatment for pancreatic exocrine insufficiency with PERT is both safe and effective. Pancrease, Pertzye, Creon, Zenpep and Viokace are some of the medications utilized in PERT. Patients with exocrine pancreatic insufficiency are unable to effectively digest proteins, lipids, and carbohydrates in their food, resulting in poor nutritional absorption.View Detailed Report: https://www.databridgemarketresearch.com/reports/global-exocrine-pancreatic-insufficiency-market
Exocrine pancreatic insufficiency is caused by pancreatitis, cystic fibrosis, and other pancreatic diseases (EPI). EPI patients lack the pancreatic (digestive) enzymes needed to break down foods and absorb nutrients. It has the potential to cause malnutrition. PERT (pancreatic enzyme replacement treatment) may be beneficial. In EPI, pancreatic replacement therapy is a well-established treatment option that helps to reduce malabsorption and malnutrition. Lipase is responsible for fat digestion, protease is responsible for protein digestion, and amylase is responsible for starch digestion in the body. The USFDA approved the following pancreatic enzyme products (PEPs) for EPI treatment in 2009: Zenpep and Creon, Viokace and Ultresa in 2012, Pancreaze in 2010, and Pertzye in 2012.
Data Bridge Market Research analyses that the exocrine pancreatic insufficiency market was valued at USD 2.27 billion in 2021 and is expected to reach USD 3.75 billion by 2029, registering a CAGR of 6.50% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Some of the major players operating in the exocrine pancreatic insufficiency market are:
AstraZeneca (UK)
Johnson & Johnson Private Limited (US)
AbbVie Inc. (US)
Allergan (Ireland)
Nordmark Arzneimittel GmbH & Co. KG (Germany)
Digestive Care, Inc. (US)
Cilian AG (Germany)
Anthera Pharmaceuticals, Inc. (US)
Eli Lilly and Company (US)
Takeda Pharmaceutical Company Limited (Japan)
Horizon Therapeutics plc (Ireland)
BioMarin (US)
Alexion Pharmaceuticals, Inc. (US)
Sanofi (France)
Abbott (US)
Opportunities
Rising number of research and development activities
The market's growth is fueled by an increase in the number of research and development activities. This will create new market opportunities. To meet the growing need for new treatments, leading companies are investing in research and development to develop and introduce new exocrine pancreatic insufficiency medicines, increasing market growth. AzurRx, for instance, is developing MS1819, a yeast-derived lipase that has been designed to have higher enzymatic activity than current treatments.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will provide beneficial opportunities for the exocrine pancreatic insufficiency market growth.
Global Exocrine Pancreatic Insufficiency Market Scope
The exocrine pancreatic insufficiency market is segmented on the basis of diagnosis, treatment, drugs, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnosis
Imaging Tests
CT scan
Abdominal ultrasound
Others
Secretin Pancreatic Function Test
Fecal Fat Test
Fecal Elastase Test (FE-1)
Treatment
Nutritional Management
Pancreatic Enzyme Replacement Therapy (PERT)
Others
Drugs
Creon
Zenpep
Pancreaze
Ultresa
Viokace
Others
Symptoms
Abdominal Pain
Constipation
Diarrhea
Fatty stools
Weight Loss
Others
End-Users
Hospitals
Specialty Clinics
Homecare
Others
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Explore More Reports:
https://manoj-mrr.blogspot.com/2024/03/retail-ready-packaging-market-to-grow.html
https://manoj-mrr.blogspot.com/2024/03/pulmonary-function-testing-market-to.html
https://manoj-mrr.blogspot.com/2024/03/polystyrene-market-registering-cagr-of.html
https://manoj-mrr.blogspot.com/2024/03/polycystic-ovarian-syndrome-pcos.html
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact Us:
Data Bridge Market Research
Tel: +1-888-389.80-2818 | +44 208 089 1725 | +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exocrine Pancreatic Insufficiency Market to reach USD 3.75 billion by 2029, registering a CAGR of 6.50%,Trends here
News-ID: 3414609 • Views: …
More Releases from Data Bridge Market Research
Fire Resistant Glass Market Advances with Intumescent Coatings, Hybrid Laminates …
Fire resistant glass market is growing at a high CAGR during the forecast period 2024-2031.
Fire Resistant Glass Market is positioned for robust growth, and shifting market dynamics reshaping the competitive landscape. DataM Intelligence's new report provides data-driven insights, SWOT analysis, and marketing-ready intelligence for businesses seeking to improve market penetration and campaign ROI.
Get your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/fire-resistant-glass-market?vs
Fire Resistant Glass Market Overview &…
Rising Demand for Advanced Treatments to Propel Obliterative Bronchiolitis Marke …
The Obliterative Bronchiolitis Market is undergoing a significant transformation, with industry forecasts predicting rapid expansion and cutting-edge technological innovations by 2032. As businesses continue to embrace digital advancements and strategic shifts, the sector is set to experience unprecedented growth, driven by rising demand, market expansion, and evolving industry trends.
A recent in-depth market analysis sheds light on key factors propelling the Obliterative Bronchiolitis market forward, including increasing market share, dynamic segmentation,…
Medical-Social Working Services Market Industry Trends and Forecast to 2030
This Medical-Social Working Services Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and…
Global Marine Insurance Market to Grow at 4.50% CAGR, Reaching USD 39.87 Billion …
The Marine Insurance Market is undergoing a significant transformation, with industry forecasts predicting rapid expansion and cutting-edge technological innovations by 2032. As businesses continue to embrace digital advancements and strategic shifts, the sector is set to experience unprecedented growth, driven by rising demand, market expansion, and evolving industry trends.
A recent in-depth market analysis sheds light on key factors propelling the Marine Insurance market forward, including increasing market share, dynamic segmentation,…
More Releases for EPI
Consumer Electronics Adoption Fuels The Silicon Epi Wafer Market: Core Growth En …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Silicon EPI Wafer Industry Market Size Be by 2025?
Over recent years, the market size for silicon EPI wafers has seen considerable growth. Predictions indicate an increase from $1.8 billion in 2024 to $1.92 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this historical…
Evolving Market Trends In The Silicon EPI Wafer Industry: Next-Generation Silico …
The Silicon EPI Wafer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Silicon EPI Wafer Market Size During the Forecast Period?
In recent times, the silicon EPI wafer market has witnessed substantial growth. The market size, which stood at $1.8 billion in…
Leading Growth Driver in the Silicon EPI Wafer Market in 2025: Consumer Electron …
What industry-specific factors are fueling the growth of the silicon epi wafer market?
The silicon EPI wafer market is expected to experience significant growth due to the increased use of consumer electronics products. Consumer electronics (CE) refers to electronic devices specifically designed for everyday use by consumers for non-commercial or professional purposes. Silicon wafers, which are semiconductors, are used in the manufacture of microchips and chips for these electronic devices. For…
EPI Invests $1 Million USD in the EPI Data Center Futurist Scholarship Program
Singapore (15 June 2023) - EPI, the global leader in data center training, audit & certification, is proud to announce the launch of the EPI Data Center Futurist Scholarship program, accompanied by a significant investment of one (1) million US-Dollar. This transformative initiative aims to provide aspiring professionals with the resources and support they need to acquire the specialized knowledge and skills necessary for success in the dynamic data…
Epi Wafer Market to Surpass Valuation of US$ 5.8 Bn by 2030 with Rising Demand f …
The global Epi Wafer market is estimated to attain a valuation of US$ 5.8 billion by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6% during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
